---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-063835"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2024-05-21T23:59:59+00:00"
generated_at: "2026-06-01T11:35:05.513762+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Haemonetics announces $525M convertible senior notes offering due 2029

## Summary
- $525M principal amount of convertible senior notes due 2029, with option for additional $75M.
- Notes accrue interest semi-annually, mature June 1, 2029; settlement in cash up to $1,000 principal, then stock/cash.
- Proceeds to fund capped call transactions to offset dilution, plus working capital and general corporate purposes.
- Offering only to qualified institutional buyers under Rule 144A; notes not registered under Securities Act.
- Option counterparties may enter derivative transactions affecting HAE stock price around pricing.

## SEC filing metadata
- accession: 0001104659-24-063835
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2024-05-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000110465924063835/0001104659-24-063835-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000110465924063835/tm2415037d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-063835
- JSON: https://secwatch.observer/filing/0001104659-24-063835.json
- Plain text: https://secwatch.observer/filing/0001104659-24-063835.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.